Panel to decide on AstraZeneca Covid vax trials after unexplained illness in UK
Published
Pharma major AstraZeneca has said it is working to expedite the review of the single event to minimise any potential impact on the trial timeline of its Covid-19 vaccine candidate.
AstraZeneca said in a statement that as part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus vaccine,...